FDA Clearance Tracker · K251198
HyperVue Software
Last checked: Nov 20, 2026Latest source record: Jul 16, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jul 16, 2025
Substantially Equivalent
Time to decision
90 days
Received Apr 17, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K251198
- Device name
- HyperVue Software
- Applicant
- Spectrawave, Inc.
- Applicant location
- Bedford, MA
- Received
- Apr 17, 2025
- Decided
- Jul 16, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.1560
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NQQ. The earliest in FDA's data is K033783, decided Mar 1, 2004.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K251198
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Spectrawave, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253101 · Decided Dec 15, 2025 · 82 days after receipt
Device type: System, Imaging, Optical Coherence Tomography (Oct) (NQQ) · Radiology & Imaging
- X1-FFR510(k)
K251355 · Decided Oct 17, 2025 · 170 days after receipt
Device type: X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device (QHA) · Radiology & Imaging
K243016 · Decided Mar 20, 2025 · 174 days after receipt
Device type: System, Imaging, Optical Coherence Tomography (Oct) (NQQ) · Radiology & Imaging
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.